Informationen:
Fehler:
ID
30072
Beschreibung
Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?; ODM derived from: https://clinicaltrials.gov/show/NCT00441597
Link
https://clinicaltrials.gov/show/NCT00441597
Stichworte
Versionen (1)
- 08.05.18 08.05.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
8. Mai 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Ischemia Reperfusion Injury NCT00441597
Eligibility Ischemia Reperfusion Injury NCT00441597
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Ischemia Reperfusion Injury NCT00441597
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Gender
Item
male
boolean
C0079399 (UMLS CUI [1])
Age
Item
age 18-50 years
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Exercise test Ischemic Ability
Item
physical able to perform ischemic exercise
boolean
C0015260 (UMLS CUI [1,1])
C0475224 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0475224 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Cardiovascular Disease
Item
history of any cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Systolic hypertension Supine Position | Diastolic hypertension Supine Position
Item
hypertension (in supine position: systole > 140 mmhg, diastole > 90 mmhg)
boolean
C0221155 (UMLS CUI [1,1])
C0038846 (UMLS CUI [1,2])
C0235222 (UMLS CUI [2,1])
C0038846 (UMLS CUI [2,2])
C0038846 (UMLS CUI [1,2])
C0235222 (UMLS CUI [2,1])
C0038846 (UMLS CUI [2,2])
Diabetes Mellitus | Glucose measurement, fasting | Glucose measurement, random
Item
diabetes mellitus (fasting glucose > 7.0 mmol/l or random glucose > 11.0 mmol/l)
boolean
C0011849 (UMLS CUI [1])
C0202045 (UMLS CUI [2])
C0202046 (UMLS CUI [3])
C0202045 (UMLS CUI [2])
C0202046 (UMLS CUI [3])
Hyperlipidemia | Serum total cholesterol measurement Fasting
Item
hyperlipidaemia (fasting total cholesterol > 5.5 mmol/l)
boolean
C0020473 (UMLS CUI [1])
C1445957 (UMLS CUI [2,1])
C0015663 (UMLS CUI [2,2])
C1445957 (UMLS CUI [2,1])
C0015663 (UMLS CUI [2,2])
Alanine aminotransferase measurement
Item
alanine-amino-transferase (alat) >90 u/l
boolean
C0201836 (UMLS CUI [1])
elevated creatinine kinase
Item
creatinine kinase (ck) >440 u/l
boolean
C1657311 (UMLS CUI [1])
Substance Use Disorders
Item
drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Medication use chronic
Item
concommitant chronic use of medication
boolean
C0240320 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,2])
Therapeutic radiology procedure
Item
administration of radioactivity in research setting during the last 5 years
boolean
C1522449 (UMLS CUI [1])
Study Subject Participation Status | Investigational New Drugs
Item
participation to any drug-investigation during the previous 60 days as checked with vip check according to crcn standard procedures
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0013230 (UMLS CUI [2])